Abstract:As a novel molecular and functional imaging modality, X-ray luminescence computed tomography (XLCT) has shown its potentials in biomedical and preclinic applications. However, there are still some limitations of X-ray-excited luminescent materials, such as low luminescence efficiency, poor biocompatibility, and cytotoxicity, making in vivo XLCT imaging quite challenging. In this study, for the very first time, we present on using sub-10 nm β-NaGdF4:X% Eu3+ nanoparticles with poly(acrylic acid) (PAA) surface modification, which demonstrate outstanding luminescence efficiency, uniform size distribution, water dispersity, and biosafety, as the luminescent probes for in vivo XLCT application. The pure hexagonal phase (β-) NaGdF4 has been successfully synthesized and characterized by X-ray powder diffraction (XRD) and transmission electron microscopy (TEM), and then the results of X-ray photoelectron spectroscopy (XPS), energy-dispersive X-ray spectrometry (EDX), and elemental mapping further confirm Eu3+ ions doped into NaGdF4 host. Under X-ray excitation, the β-NaGdF4 nanoparticles with a doping level of 15% Eu3+ exhibited the most efficient luminescence intensity. Notably, the doping level of Eu3+ has no effect on the crystal phase and morphology of the NaGdF4-based host. Afterward, β-NaGdF4:15% Eu3+ nanoparticles were modified with PAA to enhance the water dispersity and biocompatibility. The compatibility of in vivo XLCT imaging using such nanoparticles was systematically studied via in vitro cytotoxicity, physical phantom, and in vivo imaging experiments. The ultralow cytotoxicity of PAA-modified nanoparticles, which is confirmed by over 80% cell viability of SH-SY5Y cells when treated by high nanoparticle concentration of 200 μg/mL, overcome the major obstacle for in vivo application. In addition, the high luminescence intensity of PAA-modified nanoparticles enables the location error of in vivo XLCT imaging less than 2 mm, which is comparable to that using commercially available bulk material Y2O3:15% Eu3+. The proposed nanoparticles promote XLCT research into an in vivo stage. Further modification of these nanoparticles with biofunctional molecules could enable the potential of targeting XLCT imaging.

Radiopaque Fluorescence-Transparent Taox Decorated Upconversion Nanophosphors for in Vivo Ct/Mr/Ucl Trimodal Imaging

Sub-10 Nm Water-Dispersible Β-Nagdf4:X% Eu3+ Nanoparticles with Enhanced Biocompatibility for in Vivo X-ray Luminescence Computed Tomography

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Gd 3+ complex-modified NaLuF 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance

Novel lanthanide–polymer complexes for dye-free dual modal probes for MRI and fluorescence imaging

Upconversion Nanophosphors Naluf4:Yb,Tm for Lymphatic Imaging in Vivo by Real-Time Upconversion Luminescence Imaging under Ambient Light and High-Resolution X-ray CT

Efficient sub-25 nm highly Tm 3+ -doped upconversion nanoparticles for microscopic imaging

Folic Acid-Conjugated LaF3:Yb,Tm@SiO2 Nanoprobes for Targeting Dual-Modality Imaging of Upconversion Luminescence and X-ray Computed Tomography

Optimization of Bi3+ in Upconversion Nanoparticles Induced Simultaneous Enhancement of Near-Infrared Optical and X-ray Computed Tomography Imaging Capability.

Multifunctional nanomesoporous materials with upconversion (in vivo) and downconversion (in vitro) luminescence imaging based on mesoporous capping UCNPs and linking lanthanide complexes.

Porous Upconversion Nanostructures As Bimodal Biomedical Imaging Contrast Agents

Lanthanide-doped GdVO4 Upconversion Nanophosphors with Tunable Emissions and Their Applications for Biomedical Imaging

Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging.

Direct Visualization of Gastrointestinal Tract with Lanthanide-Doped BaYbF5 Upconversion Nanoprobes

Single Ho3+‐Doped Upconversion Nanoparticles for High‐Performance T2‐Weighted Brain Tumor Diagnosis and MR/UCL/CT Multimodal Imaging

Core-shell Lanthanide Upconversion Nanophosphors As Four-Modal Probes for Tumor Angiogenesis Imaging.

Enhanced dual contrast agent, Co(2+)-doped NaYF4:Yb(3+),Tm(3+) nanorods, for near infrared-to-near infrared upconversion luminescence and magnetic resonance imaging.

Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties.

Surface modification effect on contrast agent efficiency for X-ray based spectral photon-counting scanner/luminescence imaging: from fundamental study to in vivo proof of concept

Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro.

Gd3+‐Ion‐Doped Upconversion Nanoprobes: Relaxivity Mechanism Probing and Sensitivity Optimization